Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDP167 in Homozygous Familial Hypercholesterolemia
NCT07489209Phase 2Recruiting
- Sponsor
- Eddingpharm
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of EDP167 in homozygous familial hypercholesterolemia (HoFH), sponsored by Eddingpharm. Started Feb 2026; status: recruiting.
02
Drugs
EDP167
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT07489209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489209.